Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014-2018).
Chiara AzzariMaria MoriondoFrancesco NiedduValentina GuarnieriLorenzo LodiClementina CanessaGiuseppe IndolfiMattia GiovanniniGiuseppina NapoletanoFrancesca RussoTatjana BaldovinSilvia CocchioSilvia RicciVincenzo BaldoPublished in: Vaccines (2020)
In conclusion, 4CMenB appears to have a very high effectiveness in Italy; the impact of vaccination appears greater where the immunization program is started early.